Viewing Study NCT00390858


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2025-12-25 @ 10:25 PM
Study NCT ID: NCT00390858
Status: COMPLETED
Last Update Posted: 2017-03-20
First Post: 2006-10-18
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload.
Sponsor: Novartis Pharmaceuticals
Organization: